InnovAge Holding Corp.

INNVNASDAQHealthcare● Active

$7.30

+$0.10(+1.39%)

Market Cap$990872800

P/E Ratio—

52W High$10.69

52W Low$3.13

Avg Volume285K

Open$7.19

Beta0.45

Overview

InnovAge Holding Corp. (INNV) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

INNV · free cash flow · updated Jun 8, 2026

Core FCF metrics

INNV · FCF · TTM · margin & CAGR

Free cash flow was $26.6M for FY2025 (fiscal year ending 2025-06-30), up 159.4% year-over-year The FCF margin was 3.1%. Five-year CAGR stands at -3.6%.

FY2025 Free Cash Flow$26.6M▲ +159.4% YoY

Trailing 12M (TTM)$38.9Mtrailing 4 quarters sum

FCF Margin3.1%$26.6M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR-3.6%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

INNV · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$32.9M(6M)$26.6M▲ +159.4%3.1%

FY2024−$36.9M(8M)−$44.8M▲ +0.0%-5.9%

FY2023−$36.9M(8M)−$44.8M▼ 309.8%-6.5%

FY2022$27.3M(38M)−$10.9M▲ +56.4%-1.6%

FY2021−$7.5M(18M)−$25.1M▼ 178.4%-3.9%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

INNV · P/FCF · FCF yield · FCF per share

InnovAge Holding Corp. (INNV) trades at a FCF yield of 3.92% and a price-to-free-cash-flow ratio of 25.2x. FCF per share stands at $0.29, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.92%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.29

TTM FCF ÷ Shares Outstanding

Price / FCF

x25.2

Share Price ÷ FCF per Share

EV / FCF (TTM)

x25.4

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

INNV · cash flow statement · operating / investing / financing

For FY2025, InnovAge Holding Corp. generated $32.9M in operating cash flow and spent 6M in capital expenditures, yielding $26.6M in free cash flow.

Operating Activities

+$32.9M

Cash from core business operations

2025-06-30

Investing Activities

−$5.5M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

−$19.1M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF ($32.9M) − |CapEx| (6M) = FCF ($26.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

INNV vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

InnovAge Holding Corp.YOU

INNV

$26.6M+159.4%3.1%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

InnovAge Holding Corp. (INNV) reported free cash flow of $26.6M for FY2025 (fiscal year ending 2025-06-30), up 159.4% year-over-year. The FCF margin was 3.1%.

Based on available data, InnovAge Holding Corp. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $32.0M in FY2020. The 5-year CAGR stands at -3.6%.

InnovAge Holding Corp.'s FCF yield is 3.92% and price-to-FCF ratio is 25.2x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

INNV free cash flow · 8 questions

InnovAge Holding Corp. free cash flow was $26.6M for FY2025, up 159.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $38.9M.

INNV free cash flowINNV FCFINNV FCF 2025INNV free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · InnovAge Holding Corp. · InnovAge Holding Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026